Welcome to the Recombinant Antibody Network

The Recombinant Antibody Network is a consortium of highly integrated technology centers at UCSF, the University of Chicago, and the University of Toronto, unified under a common goal to generate therapeutic grade recombinant antibodies at a proteome wide scale for biology and biomedicine.

Given that over half the human proteome is not annotated and that functional antibodies are not reliably available, a complete set of validated antibodies would greatly advance all areas of biology, including cancer therapy and infectious disease control. To undertake these challenges, RAN is systematically and comprehensively profiling families of protein targets using novel, modern high-throughput in vitro technology.

Latest Publications

Site-Selective Bioconjugations of Distinct Methionine Residues in a Protein via Reactivity-Based Reagent Control

Sisko E J; Kumru K; Wells J A; Sello J K

Site-Selective Bioconjugations of Distinct Methionine Residues in a Protein via Reactivity-Based Reagent Control Journal Article

In: ACS Chem Biol, 2026, ISSN: 1554-8937.

Abstract | Links

Structural basis of serine protease inhibition by antibodies from biased Fab phage-display libraries

Anderson K J; Lee M S; Sevillano N; Chen G; Hornsby M J; Sidhu S S; Craik C S

Structural basis of serine protease inhibition by antibodies from biased Fab phage-display libraries Journal Article

In: Biol Chem, 2026, ISSN: 1437-4315.

Abstract | Links

Comparative analysis of photocatalytic, enzymatic, and chemical approaches to identify canonical and noncanonical surfaceomes

Ho W W; Chen Y; Slezak T; Zginnyk O; Peters-Clarke T M; Schaefer K; Kossiakoff A A; Leung K K; Wells J A

Comparative analysis of photocatalytic, enzymatic, and chemical approaches to identify canonical and noncanonical surfaceomes Journal Article

In: Proc Natl Acad Sci U S A, vol. 123, no. 43, pp. e2623700123, 2026, ISSN: 1091-6490.

Abstract | Links

Latest News

Scroll to Top